Sigmak Lifesciences partners with pharmaceutical manufacturers, importers, and distributors in South Africa to supply WHO-GMP sourced injectable formulations, active pharmaceutical ingredients, and specialty chemical intermediates. South Africa has the most advanced pharmaceutical sector on the continent, with SAHPRA (South African Health Products Regulatory Authority) standards among the most stringent in Africa.
The injectable portfolio covers antibiotics, anti-infectives, cardiovascular agents, analgesics, anaesthetics, vitamins, and oncology support formulations across ampoules, vials, and dry powder formats. Documentation support includes COA, COPP, CTD dossiers, and stability data aligned with SAHPRA submission requirements.
Sigmak supports both private hospital groups and state tender procurement across South Africa's nine provincial health departments, with structured supply programs for branded generic and institutional distribution.